Abstract
Keywords:
calcium; cardiomyopathies; gene expression; heart failure; therapeutics.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Aorta
-
Calcium / metabolism
-
Cardiomyopathy, Dilated / complications
-
Cardiomyopathy, Dilated / genetics
-
Cardiomyopathy, Dilated / metabolism*
-
Cytoplasm / metabolism
-
DNA-Binding Proteins / analysis
-
DNA-Binding Proteins / antagonists & inhibitors
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism*
-
Heart Failure / etiology
-
Heart Failure / metabolism
-
Heterogeneous-Nuclear Ribonucleoprotein Group C / metabolism
-
Humans
-
Mice
-
Myocardial Contraction*
-
Myocytes, Cardiac / drug effects
-
Myocytes, Cardiac / metabolism
-
Phenylephrine / pharmacology
-
RNA, Long Noncoding / analysis
-
RNA, Long Noncoding / genetics
-
RNA, Long Noncoding / metabolism*
-
RNA, Messenger / metabolism
-
Ryanodine Receptor Calcium Release Channel / genetics
-
Ryanodine Receptor Calcium Release Channel / metabolism
-
Tissue Array Analysis
-
Transcription Factors / analysis
-
Transcription Factors / antagonists & inhibitors
-
Transcription Factors / genetics
-
Transcription Factors / metabolism*
-
Vasoconstriction
Substances
-
DNA-Binding Proteins
-
HNRNPC protein, human
-
Heterogeneous-Nuclear Ribonucleoprotein Group C
-
RNA, Long Noncoding
-
RNA, Messenger
-
RyR2 protein, human
-
Ryanodine Receptor Calcium Release Channel
-
Transcription Factors
-
ZNF593 protein, human
-
Zfp593 protein, mouse
-
Phenylephrine
-
Calcium